
A new Spherix Global Insights survey shows providers want administrative support for prior authorization while patients prioritize access and affordability
FDA has approved emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Complera, Gilead Sciences), a complete single-tablet regimen for the treatment of HIV-1 infection in treatment-naïve adults.
FDA approves single-tablet regimen for HIV-1 infection in treatment-naïve adults






